Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the countries listed. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.
REZDIFFRA
Class 5 – Pharmaceuticals & supplements
Status timeline
- 22 Dec 2023Application filedNwap
- 24 Jul 2024Assigned to an examining attorneyDock
- 24 Jul 2024Approved for publicationCnsa
- 27 Aug 2024Published for oppositionPubo
- 22 Oct 2024Notice of allowance issued — statement of use requiredNoam
- 18 Apr 2025Statement of use filedEisu
- 9 Sep 2025Statement of use acceptedCnpr
- 30 Sep 2025Registered on the Principal RegisterR.pr
All 16 events
| 2025-09-30 | R.pr |
| 2025-09-30 | Nrcc |
| 2025-09-09 | Cnpr |
| 2025-09-09 | Suna |
| 2025-09-07 | Supc |
| 2025-09-05 | Aitu |
| 2025-04-18 | Eisu |
| 2025-04-18 | Iuaf |
| 2024-10-22 | Noam |
| 2024-08-27 | Pubo |
| 2024-08-27 | Npub |
| 2024-08-07 | Nonp |
| 2024-07-24 | Dock |
| 2024-07-24 | Cnsa |
| 2024-04-04 | Nwos |
| 2023-12-22 | Nwap |
Goods & services by class
Class 5 Pharmaceuticals & supplements
Pharmaceutical preparations for the treatment of patients with non-alcoholic steatohepatitis (NASH) with liver fibrosis
First use anywhere 14 Mar 2024 · First use in commerce 14 Mar 2024
Source & freshness
Source: the official United States trademark register. This record was last updated on 30 Sep 2025; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.